InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Myth PremiumMember
10/11/21 9:44 AM
profile icon
girlfriend Free
10/11/21 9:43 AM
profile icon
girlfriend Free
10/11/21 9:43 AM
profile icon
Myth PremiumMember
10/11/21 9:39 AM
profile icon
Atown62 Free
10/11/21 9:19 AM
profile icon
Atown62 Free
10/09/21 10:50 AM
profile icon
Atown62 Free
10/08/21 3:02 PM
profile icon
girlfriend Free
10/04/21 9:13 AM
profile icon
Atown62 Free
10/04/21 8:54 AM
profile icon
girlfriend Free
10/01/21 8:54 PM
profile icon
Atown62 Free
10/01/21 8:24 PM
profile icon
girlfriend Free
09/28/21 11:56 AM
profile icon
Atown62 Free
09/28/21 11:36 AM
profile icon
girlfriend Free
09/28/21 9:44 AM
profile icon
Atown62 Free
09/28/21 9:19 AM
profile icon
Atown62 Free
09/28/21 9:18 AM
profile icon
Atown62 Free
09/27/21 5:35 PM
profile icon
Atown62 Free
09/27/21 5:35 PM
profile icon
girlfriend Free
09/25/21 8:02 AM
profile icon
Atown62 Free
09/25/21 12:29 AM
profile icon
Atown62 Free
09/25/21 12:29 AM
profile icon
girlfriend Free
09/15/21 4:24 PM
profile icon
Atown62 Free
08/28/21 3:28 PM
profile icon
Atown62 Free
08/25/21 7:19 PM
profile icon
Atown62 Free
08/25/21 9:29 AM
profile icon
girlfriend Free
08/25/21 9:16 AM
profile icon
Atown62 Free
08/25/21 9:13 AM
profile icon
girlfriend Free
08/25/21 9:13 AM
profile icon
Atown62 Free
08/25/21 9:11 AM
profile icon
Atown62 Free
08/24/21 8:12 PM
profile icon
Atown62 Free
08/24/21 3:49 PM
profile icon
girlfriend Free
08/24/21 3:08 PM
profile icon
Atown62 Free
08/23/21 6:31 PM
profile icon
Myth PremiumMember
08/23/21 3:29 PM
profile icon
Atown62 Free
08/23/21 3:26 PM
profile icon
Atown62 Free
08/20/21 7:33 PM
profile icon
Myth PremiumMember
08/20/21 6:49 PM
profile icon
Atown62 Free
08/20/21 6:27 PM
profile icon
Atown62 Free
08/18/21 7:58 PM
profile icon
Myth PremiumMember
08/18/21 5:29 AM
profile icon
Myth PremiumMember
08/18/21 5:29 AM
profile icon
Atown62 Free
08/17/21 10:56 PM
profile icon
Myth PremiumMember
08/17/21 3:30 PM
profile icon
Atown62 Free
08/16/21 11:46 PM

Sarepta Therapeutics (SRPT) RSS Feed

Followers
129
Posters
362
Posts (Today)
0
Posts (Total)
3055
Created
11/16/05
Type
Free
Moderators

http://www.sareptatherapeutics.com/

http://www.antivirals.com/

http://finance.yahoo.com/q/h?s=AVII

http://www.form4oracle.com/company?cik=0000873303&ticker=avii

http://www.secform4.com/insider-trading/873303.htm
 

Sarepta Therapeutics - formerly AVI BioPharma - remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta's unique technology has yielded a diverse pipeline of RNA-based therapeutics that include our lead clinical candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, a debilitating and life-threatening genetic disorder, as well as potential treatments for some of the world's most lethal infectious diseases.

Our exceptional science- and commercialization-focused team is committed to realizing our vision of becoming a leading, independent biotechnology company dedicated to translating our RNA-based science into transformational therapeutics and, most importantly, bringing these novel therapeutics to patients who have no other options.

AVI BioPharma, Inc., a biopharmaceutical company, develops therapeutic products principally based on NEUGENE antisense technology. It offers various drugs for the treatment of cardiovascular diseases, infectious diseases, cancer, and polycystic kidney diseases, as well as for regulating drug metabolism. The company has collaboration agreement with Chiron Corporation for research, development, and commercialization of antisense therapeutics against hepatitis C virus; Cook Group Incorporated for the development and commercialization of products for vascular diseases; and Ercole Biotech, Inc. to identify and develop drugs that direct the splicing of messenger RNA to treat a range of genetic and acquired diseases. AVI BioPharma was founded in 1980 and is based in Portland, Oregon.

SEC Filings

Form Type Received Period Ending Size Report
PRE 14A May 16, 2016 Jun 27, 2016 2.7 MB  PDF    RTF    HTML    XLS
SC 13G May 6, 2016   14.4 KB  PDF    RTF    HTML    XLS
8-K May 5, 2016 May 5, 2016 72.4 KB  PDF    RTF    HTML    XLS
10-Q May 5, 2016 Mar 31, 2016 5.0 MB  PDF    RTF    HTML    XLS
10-K/A Apr 29, 2016 Dec 31, 2015 2.0 MB  PDF    RTF    HTML    XLS
4 Apr 22, 2016 Apr 20, 2016 5.0 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 7.4 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 5.2 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 4.7 KB  PDF    RTF    HTML    XLS
8-K Mar 8, 2016 Mar 7, 2016 30.8 KB  PDF    RTF    HTML    XLS
















Phone and email address..................Lead investigator in the DMD trial.....London College of Medicine

http://www1.imperial.ac.uk/medicine/people/f.muntoni/


 

DISCLAIMER:
•The Board Monitor and The Board Assistants herewith, Are not licensed brokers and assume NO Responsibility for the Actions,
 Investment decisions, and or Messages Posted on this Forum.
•We do NOT recommend that Anyone Buy or Sell any Securities Posted Herewith.
Any Trade entered into Risks the Possibility of Losing the Funds Invested.
•There are NO Guarantees when Buying or Selling Any Security.